Cannabinoid receptors in conjunctival epithelium: Identification and functional properties

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 10, 2008, Pages 4535-4544

  Iribarne, María ^a   Torbidoni, Vanesa ^a   Julián, Karina ^a   Prestifilippo, Juan P ^b   Sinha, Debasish ^c   Rettori, Valeria ^b   Berra, Alejandro ^d   Suburo, Angela M ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; TRANSCRIPTION INITIATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CONJUNCTIVA; ENZYME IMMUNOASSAY; GENE EXPRESSION; GENETICS; METABOLISM;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CONJUNCTIVA; CYCLIC AMP; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53449091205     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1319     Document Type: Article

References (51)

1. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology, XXVII: classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161-202. (Pubitemid 34575709)
2. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561-564. (Pubitemid 20238806)
3. Gerard CM, Mollereau C, Vassart G, Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J. 1991;279(pt 1):129-134.
4. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61-65. (Pubitemid 23305569)
5. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev. 2003;83:1017-1066. (Pubitemid 36828930)
6. Klein TW, Newton C, Larsen K, et al. The cannabinoid system and immune modulation. J Leukoc Biol. 2003;74:486-496.
7. Sanchez MG, Ruiz-Llorente L, Sanchez AM, Diaz-Laviada I. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells: involvement in Raf-1 stimulation and NGF induction. Cell Signal. 2003;15:851-859. (Pubitemid 36776659)
8. Gkoumassi E, Dekkers BG, Droge MJ, et al. Virodhamine and CP55940 modulate cAMP production and IL-8 release in human bronchial epithelial cells. Br J Pharmacol. 2007;151:1041-1048. (Pubitemid 47195535)
9. Maccarrone M, Di Rienzo M, Battista N, et al. The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem. 2003;278:33896-33903. (Pubitemid 37553223)
10. Ibrahim MM, Porreca F, Lai J, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A. 2005;102:3093-3098. (Pubitemid 40299921)
11. Prestifilippo JP, Fernandez-Solari J, de la Cal C, et al. Inhibition of salivary secretion by activation of cannabinoid receptors. Exp Biol Med (Maywood). 2006;231:1421-1429. (Pubitemid 44330578)
12. De Petrocellis L, Cascio MG, Di Marzo V. The endocannabinoid system: a general view and latest additions. Br J Pharmacol. 2004;141:765-774. (Pubitemid 38446177)
13. Pertwee RG. The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes (Lond). 2006;30(suppl 1):S13-S18.
14. Telek A, Biro T, Bodo E, et al. Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J. 2007;21:3534-3541. (Pubitemid 350075143)
15. Guzman M. Cannabinoids: potential anticancer agents. Nat Rev Cancer. 2003;3:745-755.
16. Hart S, Fischer OM, Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 2004;64:1943-1950. (Pubitemid 38339438)
17. Wright K, Rooney N, Feeney M, et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology. 2005;129:437-453. (Pubitemid 41096632)
18. Felder CC, Joyce KE, Briley EM, et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol. 1995;48:443-450.
19. Guzman M. Effects on cell viability. Handb Exp Pharmacol. 2005 627-642.
20. Faubert BL, Kaminski NE. AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun. J Leukoc Biol. 2000;67:259-266.
21. Rueda D, Galve-Roperh I, Haro A, Guzman M. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol. 2000;58:814-820. (Pubitemid 30761297)
22. Derkinderen P, Ledent C, Parmentier M, Girault JA. Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem. 2001;77:957-960. (Pubitemid 32466793)
23. Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol. 2007;18:129-140. (Pubitemid 46412082)
24. Nucci C, Gasperi V, Tartaglione R, et al. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Invest Ophthalmol Vis Sci. 2007;48:2997-3004. (Pubitemid 351261139)
25. Chen J, Matias I, Dinh T, et al. Finding of endocannabinoids in human eye tissues: implications for glaucoma. Biochem Biophys Res Commun. 2005;330:1062-1067. (Pubitemid 40502050)
26. McIntosh BT, Hudson B, Yegorova S, Jollimore CA, Kelly ME. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells. Br J Pharmacol. 2007;152:1111-1120. (Pubitemid 350166054)
27. He F, Song ZH. Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells. Mol Vis. 2007;13:1348-1356. (Pubitemid 47189062)
28. Diebold Y, Calonge M, Enriquez de Salamanca A, et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 2003;44:4263-4274. (Pubitemid 37186260)
29. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292. (Pubitemid 32848857)
30. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211. (Pubitemid 29500267)
31. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45:4293-4301. (Pubitemid 39564653)
32. Tseng SC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985;92:728-733.
33. Suburo AM, Wheatley SC, Horn DA, et al. Intracellular redistribution of neuropeptides and secretory proteins during differentiation of neuronal cell lines. Neuroscience. 1992;46:881-889.
34. Sinha D, Bonner TI, Bhat NR, Matsuda LA. Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies. J Neuroimmunol. 1998;82:13-21. (Pubitemid 28129331)
35. Iribarne M, Ogawa L, Torbidoni V, Dodds CM, Dodds RA, Suburo AM. Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice. Am J Pathol. 2008;172:1030-1042.
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63. (Pubitemid 14203433)
37. Kitano A, Saika S, Yamanaka O, et al. Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci. 2007;48:5013-5022. (Pubitemid 351260911)
38. Zajicek G, Perry A, Pe'er J. Streaming of labelled cells in the conjunctival epithelium. Cell Prolif. 1995;28:235-243.
39. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med. 2003;9:575-581. (Pubitemid 36597104)
40. Buchweitz JP, Karmaus PW, Harkema JR, Williams KJ, Kaminski NE. Modulation of airway responses to influenza A/PR/8/34 by Delta9- tetrahydrocannabinol in C57BL/6 mice. J Pharmacol Exp Ther. 2007;323:675-683.
41. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002;12:258-266. (Pubitemid 34634174)
42. Herring AC, Kaminski NE. Cannabinol-mediated inhibition of nuclear factor-κB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes. J Pharmacol Exp Ther. 1999;291:1156-1163.
43. Ligresti A, Moriello AS, Starowicz K, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther. 2006;318:1375-1387. (Pubitemid 44268348)
44. Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 1995;369:177-182.
45. Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol. 2003;64:1271-1276. (Pubitemid 37532215)
46. Liang H, Baudouin C, Labbe A, et al. In vivo confocal microscopy and ex vivo flow cytometry: new tools for assessing ocular inflammation applied to rabbit lipopolysaccharide-induced conjunctivitis. Mol Vis. 2006;12:1392-1402. (Pubitemid 44932833)
47. Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res. 2006;82:588-596. (Pubitemid 43122089)
48. Kase S, Aoki K, Harada T, et al. Activation of nuclear factor-κB in the conjunctiva with the epithelial scraping of the mouse cornea and human epidemic keratoconjunctivitis. Br J Ophthalmol. 2004;88:947-949. (Pubitemid 38869561)
49. Rajesh M, Mukhopadhyay P, Batkai S, et al. Cannabinoid-2 receptor stimulation attenuates TNFα-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol. 2007;293:H2210-H2218. (Pubitemid 47605864)
50. De Filippis D, Russo A, De Stefano D, et al. Local administration of WIN 55212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-κB activation. J Mol Med. 2007;85:635-645. (Pubitemid 46870895)
51. Di Marzo V, Izzo AA. Endocannabinoid overactivity and intestinal inflammation. Gut. 2006;55:1373-1376.